Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
161.3 USD | +0.33% | -0.89% | +4.07% |
05-13 | AbbVie, Gilgamesh Pharmaceuticals Partner to Develop Therapies for Psychiatric Disorders | MT |
05-09 | Medincell: share price rises on resumption of trading | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.07% | 285B | |
+29.98% | 682B | |
+30.34% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+16.21% | 240B | |
+9.66% | 209B | |
-6.83% | 203B | |
+7.09% | 165B | |
-1.22% | 161B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Top Midday Gainers